Recurrent Breast Cancer Terminated Phase 2 Trials for Gemcitabine (DB00441)

Also known as: Breast Cancer Recurrent / Breast cancer NOS recurrent / Carcinoma breast recurrent / Breast carcinoma recurrent / Breast carcinoma NOS recurrent

IndicationStatusPhase
DBCOND0028640 (Recurrent Breast Cancer)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT000958883-AP and Gemcitabine in Treating Patients With Refractory Metastatic Breast CancerTreatment
NCT00159458Clinical Trial of Gemcitabine and Oxaliplatin in Recurrent or Metastatic Breast CancerTreatment